What is Your Tumor's Mutation Burden? - Metastatic Breast Cancer Trial Talk

Research News

The term “tumor mutation burden” refers to the number of mutations, or changes, seen in the DNA of your cancer cells. It is now one of the biomarkers used to determine cancer treatments. Studies suggest that tumors with a high number of mutations may be more likely to respond to a type of immunotherapy called a checkpoint inhibitor.

Below you can read more about how researchers are using tumor mutation burden to determine which treatments might be best for which patients. You will also find articles specific to studies that have looked at the relationship between tumor mutation burden and treatment outcomes in patients with metastatic breast cancer.

Last Modified on February 10, 2021



for past articles or specific information.